Abstract:Background: BALB/c and C57BL/6 mouse strains are commonly used in allergy research. The current study investigated the immunological differences between these two mouse strains with a locally allergic rhinitis model. Methods: Eighteen BALB/c and eighteen C57BL/6 mice received different doses of ovalbumin (OVA) intranasally for eight weeks (each mouse strain has three subgroups, 25 mg/mL group, 0.25 mg/mL group, and the PBS group). The allergic symptoms, OVA-specific serum antibody (IgE, IgG1, IgG2a), cytokines (IL-4, IFN-γ, IL-10) in the splenic culture supernatant, infiltrating eosinophils and goblet cells in local nasal mucosa were measured. RNA-seq technology was applied to detect differential gene expression in the local nasal mucosa. Results: With the same dose of OVA stimulation, the exacerbation of allergic symptoms was more pronounced in C57BL/6 than in BALB/c. BALB/c serum IgE, IgG1, and IgG2a gradually increased, and C57BL/6 produced fewer serum antibodies IgE and IgG1, while IgG2a never increased. BALB/c spleen cell culture supernatant IL-4 and IL-10 increased with increasing dose, and IFN-γ increased significantly in the intermediate dose group, while IL-4, IL-10, and IFN-γ did not increase in C57BL/6. The infiltration of eosinophils and goblet cells in both mice was proportional to the dose, while C57BL/6 was elevated more than BALB/c. RNA-seq suggested that the innate immune response, immune system process function, Jun kinase (JNK) pathway, and MAPKK pathway were upregulated in C57BL/6 compared to BALB/c. The core genes responsible for the differential immune response in both mice with allergic rhinitis were Kng2, Kng1, Gnb3, Lpar3, Lpar1, Pik3r1, Pf4, Apob, Rps9, and Fbxo2. Conclusion: There are significant differences in the immunologic responses between BALB/c mice and C57BL/6 mice. BALB/c mice developed mild local allergic inflammatory reactions and strong systemic immune responses. In contrast, C57BL/6 mice had stronger local allergic inflammatory responses and relatively mild systemic immune responses. Different mice strains can be selected according to the research purpose.

The study of the role of purified anti-mouse CD193 (CCR3) antibody in allergic rhinitis mouse animal models

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

CCR3 Monoclonal Antibody Inhibits Airway Eosinophilic Inflammation and Mucus Overproduction in a Mouse Model of Asthma

An Antagonist for CCR4 Alleviates Murine Allergic Rhinitis by Intranasal Administration

Experimental observation of the effect of immunotherapy on CD4+ T cells and Th1/Th2 cytokines in mice with allergic rhinitis

Integration of Transcriptomics and Metabolomics to Reveal the Effect of Ginsenoside Rg3 on Allergic Rhinitis in Mice

Human C-C Chemokine Receptor 3 Monoclonal Antibody Inhibits Pulmonary Inflammation in Allergic Mice

Alleviation of Murine Allergic Rhinitis by C19, a C-terminal Peptide of Chemokine-Like Factor 1 (CKLF1)

CCR3 gene knockout inhibits proliferation, differentiation, and migration of eosinophils in allergic rhinitis model mice

CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model

In Vivo Intranasal Anti-Cd23 Treatment Inhibits Allergic Responses in a Murine Model of Allergic Rhinitis.

Gene knockdown of CCR3 reduces eosinophilic inflammation and the Th2 immune response by inhibiting the PI3K/AKT pathway in allergic rhinitis mice

Analysis of expression of ILC2 cells in nasal mucosa based on animal model of allergic bacterial infection rhinitis

Lactoferrin Administration Into The Nostril Alleviates Murine Allergic Rhinitis And Its Mechanisms

Histological and Immunological Observations of Bacterial and Allergic Chronic Rhinosinusitis in the Mouse

Ameliorative Effect of Selective NLRP3 Inflammasome Inhibitor MCC950 in an Ovalbumin-Induced Allergic Rhinitis Murine Model.

A Preliminary Study in Immune Response of BALB/c and C57BL/6 Mice with a Locally Allergic Rhinitis Model

The role of interleukin-22 in the treatment of allergic rhinitis of mice

Inhibition of TRPA1 Reduces Airway Inflammation and Hyperresponsiveness in Mice with Allergic Rhinitis.

The function and mechanism of Human nasal mucosa-derived mesenchymal stem cells in allergic rhinitis in mice

MicroRNA-345-5p acts as an anti-inflammatory regulator in experimental allergic rhinitis via the TLR4/NF-κB pathway